Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma
This study has been completed.
Study NCT01359696   Information provided by Genentech, Inc.

First Received on May 23, 2011.   Last Updated on October 6, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
Interventions listed in this trial
More general drug interventions related to this trial
Sponsors listed in this trial